Pathologic nodal metastasis assessment using tumour-derived molecular features in patients with lung adenocarcinoma
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
|---|---|
| Enthalten in: |
Clinical and translational medicine - 14(2024), 4 vom: 01. Apr., Seite e1638 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Wang, Shijie [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 03.04.2024 Date Revised 17.04.2024 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1002/ctm2.1638 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370480171 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370480171 | ||
| 003 | DE-627 | ||
| 005 | 20240418232918.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240403s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/ctm2.1638 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1379.xml |
| 035 | |a (DE-627)NLM370480171 | ||
| 035 | |a (NLM)38558516 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Wang, Shijie |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Pathologic nodal metastasis assessment using tumour-derived molecular features in patients with lung adenocarcinoma |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.04.2024 | ||
| 500 | |a Date Revised 17.04.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 700 | 1 | |a Zhou, Zhiwei |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Song |e verfasserin |4 aut | |
| 700 | 1 | |a Guo, Rongyun |e verfasserin |4 aut | |
| 700 | 1 | |a Ma, Zeming |e verfasserin |4 aut | |
| 700 | 1 | |a Zhao, Dachuan |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Liang |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Yinan |e verfasserin |4 aut | |
| 700 | 1 | |a Ma, Yuanyuan |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Jianzhi |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Sha |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Yedan |e verfasserin |4 aut | |
| 700 | 1 | |a Ou, Qiuxiang |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Jinfeng |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical and translational medicine |d 2012 |g 14(2024), 4 vom: 01. Apr., Seite e1638 |w (DE-627)NLM224642685 |x 2001-1326 |7 nnns |
| 773 | 1 | 8 | |g volume:14 |g year:2024 |g number:4 |g day:01 |g month:04 |g pages:e1638 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/ctm2.1638 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 14 |j 2024 |e 4 |b 01 |c 04 |h e1638 | ||